---
product_id: 556994053
title: "– The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series)"
price: "490.77 DT"
currency: TND
in_stock: true
url: https://www.desertcart.tn/products/556994053-the-maudsley-deprescribing-guidelines-antidepressants-benzodiazepines-gabapentinoids-and-z-drugs
store_origin: TN
region: Tunisia
---

# Step-by-step tapering schedules Covers 4 major drug classes Evidence-based clinical research – The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series)

**Price:** 490.77 DT
**Availability:** ✅ In Stock

## Summary

> 📘 Master the art of safe deprescribing — because your mental health deserves expert care.

## Quick Answers

- **What is this?** – The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series)
- **How much does it cost?** 490.77 DT with free shipping
- **Is it available?** Yes, in stock and ready to ship
- **Where can I buy it?** [www.desertcart.tn](https://www.desertcart.tn/products/556994053-the-maudsley-deprescribing-guidelines-antidepressants-benzodiazepines-gabapentinoids-and-z-drugs)

## Best For

- Customers looking for quality international products

## Why This Product

- Free international shipping included
- Worldwide delivery with tracking
- 15-day hassle-free returns

## Key Features

- • **Inclusive & Accessible:** Essential for psychiatrists, GPs, pharmacists, nurses, and informed patients seeking safe medication discontinuation.
- • **Precision Tapering Protocols:** Tailored stepwise guidance for safely reducing antidepressants, benzodiazepines, gabapentinoids, and Z-drugs.
- • **Clinically Validated Insights:** Backed by WHO recommendations and cutting-edge research, ensuring authoritative and trusted deprescribing methods.
- • **Comprehensive Troubleshooting:** Practical solutions for managing withdrawal challenges like akathisia and protracted symptoms.
- • **Withdrawal vs Relapse Clarity:** Clear differentiation between withdrawal symptoms and relapse, empowering clinicians to support patients effectively.

## Overview

The Maudsley Deprescribing Guidelines is a definitive, evidence-based handbook offering step-by-step, clinically validated protocols for safely tapering and stopping antidepressants, benzodiazepines, gabapentinoids, and Z-drugs. Endorsed by WHO and grounded in the latest research, it equips healthcare professionals and patients with clear strategies to distinguish withdrawal from relapse, troubleshoot complications, and personalize tapering schedules—filling a critical gap in psychiatric medication management.

## Description

From the brand This growing franchise of world-renowned, evidence-based, reference guidelines is essential for all mental health practitioners. Written by trusted and highly respected authoring teams these guidelines are a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing. This growing franchise of world-renowned, evidence-based, reference guidelines is essential for all mental health practitioners. Written by trusted and highly respected authoring teams these guidelines are a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing. Discover more today Visit the store Discover more today Visit the store

## Technical Specifications

| Specification | Value |
|---------------|-------|
| Best Sellers Rank | 75,504 in Books ( See Top 100 in Books ) 1,021 in Scientific Psychology & Psychiatry |
| Customer reviews | 4.7 4.7 out of 5 stars (254) |
| Dimensions  | 16.76 x 3.05 x 24.13 cm |
| Edition  | 1st |
| ISBN-10  | 111982298X |
| ISBN-13  | 978-1119822981 |
| Item weight  | 1.1 kg |
| Language  | English |
| Part of series  | The Maudsley Prescribing Guidelines |
| Print length  | 592 pages |
| Publication date  | 15 Feb. 2024 |
| Publisher  | Wiley-Blackwell |

## Images

![– The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series) - Image 1](https://m.media-amazon.com/images/I/71qG59VbNcL.jpg)

## Available Options

This product comes in different **Media Format** options.

## Frequently Bought Together

- The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series)
- The Maudsley Prescribing Guidelines in Psychiatry (The Maudsley Prescribing Guidelines Series)
- The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry (The Maudsley Prescribing Guidelines Series)

---

## Why Shop on Desertcart?

- 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016
- 🌍 **Shop Globally** — Access 737+ million products across 21 categories
- 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price
- 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members)
- 🔒 **Secure Payments** — Trusted payment options with buyer protection
- ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews

**Shop now:** [https://www.desertcart.tn/products/556994053-the-maudsley-deprescribing-guidelines-antidepressants-benzodiazepines-gabapentinoids-and-z-drugs](https://www.desertcart.tn/products/556994053-the-maudsley-deprescribing-guidelines-antidepressants-benzodiazepines-gabapentinoids-and-z-drugs)

---

*Product available on Desertcart Tunisia*
*Store origin: TN*
*Last updated: 2026-10-29*